期刊文献+

毛细管气相色谱法测定盐酸金刚乙胺片的溶出度

Capillary GC Determination of Dissolution of Rimantadine Hydrochloride Tablets
下载PDF
导出
摘要 目的建立GC法测定盐酸金刚乙胺片溶出度的方法。方法照《中国药典》2010年版二部附录溶出度测定法中第二法,以蒸馏水500mL为溶剂,转速50r.min-1,30min时采样。采样后以GC法测定,经氢氧化钠碱化处理,正己烷提取,以金刚烷为内标物质,采用分流进样法,以RESTEK Rtx-5毛细管色谱柱(30 m×0.32 mm×0.25μm)为分析柱进行分离测定。结果盐酸金刚乙胺在3.98~79.60μg范围内线性关系良好(r=0.9999);平均回收率为99.82%,RSD=0.56%(n=9)。结论该方法简便、快速、准确,能有效控制盐酸金刚乙胺片的质量。 Objective To establish a GC method for detecting dissolution of rimantadine hydrochloride tablets. Methods According to AppendixX C Ⅱ of ChP (2010 edition) Vol. Ⅱ , sampling was performed under conditions of dissolution medium 500 mL of water and rotating speed 50 rpm at 30min. Then the dissolution solution of the tablets was taken and analyzed by the GC method. The solution was alkalized with sodium hydroxide, and diluted by n-hexane, and then separated by Rtx-5 capillary column (30 m×0.32 mm× 0.25 μm) with split injection, using adamantine as the internal reference. Results A good linearity of rimantadine hydrochloride was achieved in the range of 3.98-79.60 μg, with average recovery of 99.82%, RSD=0.56% (n=9). Conclusion The method is accurate, simple, rapid method with good reproducibility for the quality control of rimantadine hydrochloride tablets.
出处 《中国药事》 CAS 2013年第1期45-47,54,共4页 Chinese Pharmaceutical Affairs
关键词 盐酸金刚乙胺 盐酸金刚乙胺片 溶出度 毛细管气相色谱法 rimantadine hydrochloride rimantadine hydrochloride tablets dissolution~ capillarygas chromatography
  • 相关文献

参考文献8

二级参考文献14

  • 1Neumann G,Noda T,Kawaoka Y.Emergence and pandemic potential of swine-origin H1N1 influenza virus[J].Nature,2009,459:931-939. 被引量:1
  • 2Soundararajan V,Tharakaraman K,Raman R,et al.Extrapolating from sequence-the 2009 H1N1"swine"influenza virus[J].Nat Biotechnol.2009,27:510-513. 被引量:1
  • 3Chen Z,Wang W,Zhou H,et al.Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs[J].J Virol.2010,84(1):44-51. 被引量:1
  • 4新药(西药)临床及临床前研究指导原则[S].中国人民共和国卫生部药政局.1993:170-171. 被引量:1
  • 5国家食品药品监督管理局国家药品标准[S].WS1-(X-251)-2004Z. 被引量:1
  • 6Dharan NJ; Gubareva LV; Meyer JJ,et al.Infection with oseltamivir-resistant influenza A (H1N1) virus in the United States[J].JAMA,2009,301(10):1034-1041. 被引量:1
  • 7Eriksson B,Helgstrand E,Johansson NG,et al.Inhibition of influenza virus riboncleic acid polymerase by ribavirin triphosphate[J].Antimicrob Agents Chemoth,1977,p.946-951. 被引量:1
  • 8Rohloff J C,Kent K M,Postich M J,et al.Practical total synthesis of the anti-influenza drug GS-4104[J].Org Chem,1998,63(13):4545-4550. 被引量:1
  • 9高长有.盐酸金刚乙胺防治流行性感冒的疗效分析[J].临床心身疾病杂志,2007,13(5):442-442. 被引量:2
  • 10Johnson DC. Study of antiviral agents adamantanamine and rimanta- dine[J] . Postgrad Med, 1988, 83(2) : 136-138. 被引量:1

共引文献357

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部